Technical analysis of Profound Medical Corp. (PROF): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland.
Price Performance
| 1 month | -17.23% |
| 3 months | -14.70% |
| Year-to-date | -25.54% |
| 1 year | +41.89% |
| 3 years | -39.02% |
52-Week Range
| 52-week High | $8.95 |
| 52-week Low | $3.90 |
| Avg Volume (90d) | 94K |
Technical Indicators
| SMA 50 | $6.90 |
| SMA 200 | $6.90 |
| Beta | 0.47 |
| 30-day Volatility (annualised) | 56.0% |
| Price vs SMA 50 | -15.1% |
| Price vs SMA 200 | -15.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $6.07 | |
| 2025-11 | $6.60 | +8.7% |
| 2025-12 | $7.87 | +19.2% |
| 2026-01 | $7.50 | -4.7% |
| 2026-02 | $7.61 | +1.5% |
| 2026-03 | $6.48 | -14.8% |
| 2026-04 | $6.70 | +3.4% |
| 2026-05 | $6.81 | +1.6% |
| 2026-06 | $6.65 | -2.3% |
| 2026-07 | $7.38 | +11.0% |
| 2026-08 | $6.80 | -7.9% |
| 2026-09 | $5.86 | -13.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-16 | | |
| 2026-09-16 | $0.24 | $4.55B |
| 2026-09-16 | $1.28 | $8.32B |
| 2026-09-16 | | |
| 2026-09-16 | $0.18 | $3.43B |
| 2026-09-16 | | |
Price
| Price | $5.86 |
| Market Cap | $213M |
| Exchange | NASDAQ |
| Country | CA |
Valuation Ratios
| Price / Book | 4.08 |
| EV / EBITDA | -5.25 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.15 |
| Current Ratio | 6.46 |